Structural Heart > LOTUS Edge™ Aortic Valve System
LOTUS Edge™ Aortic Valve System
Designed to offer complete control and predictable results, the LOTUS Edge Aortic Valve System features a proprietary frame and Adaptive Seal™ that virtually eliminate paravalvular leak (PVL), exclusive deployment technology for reduced procedural complications and 100% repositionability to optimize patient outcomes.
Complete Control. Predictable Results.
LOTUS Edge R&D Updates
Hear about the design process for LOTUS Edge and how our commitment to continual innovation and physician collaboration helped us develop a transcatheter heart valve that offers flexibility, simplicity and placement precision.
Next-Generation TAVR Technology
The LOTUS Edge Aortic Valve System is a next-generation, controlled expansion TAVR valve designed to provide unmatched freedom from paravalvular leak (PVL), precise delivery with the ability to reposition after deployment, and predictable results.
1-Year Primary Effectiveness Endpoint*†
Superiority P < 0.001
Proven Clinical Outcomes
In the REPRISE III TAVR clinical trial, the LOTUS Valve platform demonstrated significantly lower moderate to severe PVL, significantly lower disabling stroke rates and superior procedural outcomes versus Evolut R™/CoreValve™.
Be Part Of Our Vision
We take partnership to heart. Join our community to receive updates and help us advance the treatment of structural heart therapies.
LOTUS Edge Design
See how the LOTUS Edge Aortic Valve System was designed to offer surgical-like PVL, consistent delivery and 100% respositionability.
Superior Clinical Outcomes
See more clinical data showing superior paravalvular leak, stroke and procedural outcomes for LOTUS Edge.